Rational Drug Design
Structure-based drug design is now a common method used by thepharmaceutical industry to identify a lead compound and take it forwardfor further development. Adam Todd, Roz Anderson and Paul W.Groundwater describe the methods used to identify and characterise atarget for structured drug design and illustrate how pharmacists canplay an important role in this process
Related Conference of Rational Drug Design
Rational Drug Design Conference Speakers
Recommended Sessions
- 2D & 3D Printing in Drug Delivery
- Advance Topics in Drug Delivery
- Biomarkers Detection & Nanoparticle Based Drug Delivery Systems
- Biopharmaceutics and Biologic Drugs
- Challenges in Delivery of Therapeutic Genomics and Proteomics
- Drug Delivery Behaviors By NMR Spectroscopy
- Drug Delivery Research
- Drug Targeting and Design
- Immunotherapy and Vaccines
- Medical Devices for Drug Delivery
- Medicinal Chemistry and Drug Discovery
- Nanomedicine & Nanotechnology
- Nanomedicine for women’s Healthcare
- Nanotechnology in Drug Delivery - Heart Disease
- Novel Drug Delivery Systems
- Peptides and Protein Drug Delivery
- Pharmaceutical Regulatory Affaris
- Pharmaceutical Marketing
- Pharmaceutical Technology
- Pharmaceutics & Biopharmaceutics
- Pharmacokinetics and pharmacodynamics
- Pre-formulation & formulation Aspects
- Rational Drug Design
- Smart Drug Delivery Systems
- Sustained Release Drug Delivery